Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
331
-
Total 13F shares, excl. options
-
27.3M
-
Shares change
-
-1.32M
-
Total reported value, excl. options
-
$4.46B
-
Value change
-
-$289M
-
Put/Call ratio
-
0.41
-
Number of buys
-
142
-
Number of sells
-
-217
-
Price
-
$163.59
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q1 2022
415 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q1 2022.
Medpace Holdings, Inc. - Common Stock (MEDP) has 331 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.3M shares
of 30.9M outstanding shares and own 88.33% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.79M shares), VANGUARD GROUP INC (3.13M shares), WASATCH ADVISORS INC (2.73M shares), STATE STREET CORP (900K shares), Invesco Ltd. (894K shares), Echo Street Capital Management LLC (695K shares), Boston Trust Walden Corp (675K shares), DIMENSIONAL FUND ADVISORS LP (657K shares), Vulcan Value Partners, LLC (562K shares), and GEODE CAPITAL MANAGEMENT, LLC (544K shares).
This table shows the top 331 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.